Mechanisms of Neutrophil-induced Liver Toxicity
Mechanisms of Neutrophil-induced Liver Toxicity
批准号:
7869223
负责人:
HARTMUT W. JAESCHKE
金额:
$32.74万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2013-06-30
关键词:
Alcoholic HepatitisAntioxidantsAttenuatedCell DeathCell physiologyCellsCholestasisClinicalCysteineDataDevelopmentDiffuseElectronsEthanolExcisionFunctional disorderFundingGene ExpressionGenesHepaticHepatocyteHepatotoxicityHost DefenseHydrogen PeroxideHypochlorous AcidIn VitroInflammatoryInflammatory ResponseInjuryInvadedInvestigationIschemiaIschemic PreconditioningKupffer CellsLeadLeukocytesLiverMediatingMembrane PotentialsMorbidity - disease rateMusNADPH OxidaseNecrosisNeoplasm TransplantationOperative Surgical ProceduresOxidantsPathologyProceduresReactive Oxygen SpeciesRecruitment ActivityReperfusion InjuryReperfusion TherapyRoleSeptic ShockSteatohepatitisSulfhydryl CompoundsSuperoxidesTestingTherapeuticTissuesUp-Regulationbasecell injurycell killingcell typeinsightliver transplantationmacrophagemicroorganismmitochondrial dysfunctionmitochondrial membranemortalityneutrophilnovel therapeuticsoxidant stresspolypeptidepre-clinicalpreventprotective effectpublic health relevanceresponsetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ischemia-reperfusion (IRP) injury is an important clinical problem, which determines morbidity and mortality after liver transplantation, liver surgery and hemorrhagic or septic shock. IRP injury is an even bigger issue in steatotic livers. A self-perpetuating inflammatory response is a key component of the overall tissue injury during reperfusion. Resident macrophages (Kupffer cells) and recruited neutrophils are the main cell types directly responsible for parenchymal cell damage. Reactive oxygen species (ROS) generated by these inflammatory cells diffuse into hepatocytes and trigger an intracellular oxidant stress, which ultimately causes necrotic cell death. Sulfhydryl groups can provide the necessary electrons to reductively inactivate these ROS. Therefore, we hypothesize that strengthening the endogenous antioxidant capacity in target cells may be most effective in preventing cell injury by Kupffer cells and neutrophils and thereby attenuating the inflammatory response without compromising vital host-defense functions of these cells. Metallothioneins (MTs) are sulfhydryl-rich polypeptides, which contain 18-23 cysteine residues per molecule. MT-1 and MT-2 are highly inducible genes and have been shown to be effective scavengers of ROS in vitro. However, virtually nothing is known about the induction of MTs during hepatic IRP or ischemic preconditioning in both lean and steatotic livers. Therefore, the overall aims of this proposal are to provide a comprehensive analysis of the postischemic gene expression of metallothioneins and to study their pathophysiological role during hepatic IRP injury in lean livers and ethanol-induced steatotic livers as well as their potential to use MT gene expression as therapeutic target. Hence our specific experimental aims are: 1./2. Characterize postischemic induction of MTs and evaluate the potential protection against a Kupffer cell and neutrophil-induced oxidant stress and injury or its effects on micro-circulatory dysfunction during IRP injury in lean and steatotic livers. 3. Evaluate the induction of MTs during ischemic preconditioning and its overall impact on the protective effects of this procedure in lean and steatotic livers. 4. Study hepatoprotective mechanisms of MT induction in cultured mouse hepatocytes. The project will provide the preclinical basis for the development of a novel therapeutic strategy, which selectively targets the detrimental effects of an excessive inflammatory response during reperfusion without compromising the host defense function of neutrophils and Kupffer cells. Public Health Relevance: An inflammatory response with activation of Kupffer cells and neutrophils contribute to a wide variety of liver pathologies including hepatic ischemia-reperfusion injury (transplantation, tumor resections), alcoholic hepatitis, steatohepatitis and obstructive cholestasis. However, these leukocytes also fulfill a vital host defense function against invading microorganisms. Therefore, it is critical to identify and test novel therapeutic strategies, which selectively target the detrimental effects of an excessive inflammatory response without compromising the host defense function of neutrophils and Kupffer cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B: Liver Cell Isolation Core
-
批准号:10013240
-
项目类别:
-
资助金额:$28.27万
-
财政年份:2016
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mechanisms of Liver Injury and Diseases
-
批准号:9073977
-
项目类别:
-
资助金额:$112.73万
-
财政年份:2016
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mechanisms of Liver Injury and Diseases
-
批准号:10013236
-
项目类别:
-
资助金额:$107.72万
-
财政年份:2016
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Core A: Administrative Core
-
批准号:10013237
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2016
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mechanisms of Liver Injury and Diseases
-
批准号:9769772
-
项目类别:
-
资助金额:$108.45万
-
财政年份:2016
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mitochondrial Dysfunction and Drug Hepatotoxicity
-
批准号:8012062
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2010
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Nuclear Receptors in Liver Health and Disease
-
批准号:8150136
-
项目类别:
-
资助金额:$216.01万
-
财政年份:2006
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Nuclear Receptors in Liver Health and Disease
-
批准号:8701308
-
项目类别:
-
资助金额:$201.55万
-
财政年份:2006
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Nuclear Receptors in Liver Health and Disease
-
批准号:8897404
-
项目类别:
-
资助金额:$197.78万
-
财政年份:2006
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Nuclear Receptors in Liver Health and Disease
-
批准号:8526481
-
项目类别:
-
资助金额:$197.75万
-
财政年份:2006
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Nuclear Receptors in Liver Health and Disease
-
批准号:8327772
-
项目类别:
-
资助金额:$217.63万
-
财政年份:2006
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mitochondrial Dysfunction and Drug Hepatotoxicity
-
批准号:6988972
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2005
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mitochondrial Dysfunction and Drug Hepatotoxicity
-
批准号:7101900
-
项目类别:
-
资助金额:$34.51万
-
财政年份:2005
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mitochondrial Dysfunction and Drug Hepatotoxicity
-
批准号:7488305
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2005
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mitochondrial Dysfunction and Drug Hepatotoxicity
-
批准号:7657498
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2005
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mitochondrial Dysfunction and Drug Hepatotoxicity
-
批准号:7273759
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2005
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
NEUTROPHIL-INDUCED LIVER INJURY TOXICITY
-
批准号:6227366
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2001
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mechanisms of Neutrophil-induced Liver Toxicity
-
批准号:8299985
-
项目类别:
-
资助金额:$31.47万
-
财政年份:2001
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
Mechanisms of Neutrophil-induced Liver Toxicity
-
批准号:7653844
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2001
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
NEUTROPHIL-INDUCED LIVER INJURY TOXICITY
-
批准号:6509411
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2001
-
负责人:HARTMUT W. JAESCHKE
-
依托单位:
海外基金